FDA 483 - Prisha Cosmetics, Inc. - November 22, 2024

Prisha Cosmetics Inc, a drug manufacturer in Chatsworth, CA, was cited for significant deficiencies across its production, laboratory, quality, materials, and equipment systems. The inspection revealed inadequate process validation, lack of stability testing, failures in quality control unit responsibilities, insufficient component testing, and unvalidated equipment and cleaning procedures. These issues indicate a broad lack of adherence to good manufacturing practices for drug products.